Yadin Rozov - 12 Sep 2025 Form 4 Insider Report for Dave Inc./DE (DAVE)

Role
Director
Signature
/s/ Joan Aristei as Attorney-in-Fact for Yadin Rozov
Issuer symbol
DAVE
Transactions as of
12 Sep 2025
Transactions value $
-$1,077,816
Form type
4
Filing time
12 Sep 2025, 17:56:32 UTC
Previous filing
05 Sep 2025
Next filing
13 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Rozov Yadin Director C/O DAVE INC., 1265 SOUTH COCHRAN AVENUE, LOS ANGELES /s/ Joan Aristei as Attorney-in-Fact for Yadin Rozov 12 Sep 2025 0001921268

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DAVE Class A Common Stock Sale -$676 -3 0% $225.21 79.9K 12 Sep 2025 Direct F1
transaction DAVE Class A Common Stock Sale -$192K -848 -1.06% $226.80 79.1K 12 Sep 2025 Direct F1, F2
transaction DAVE Class A Common Stock Sale -$561K -2.46K -3.11% $227.90 76.6K 12 Sep 2025 Direct F1, F3
transaction DAVE Class A Common Stock Sale -$188K -822 -1.07% $228.64 75.8K 12 Sep 2025 Direct F1, F4
transaction DAVE Class A Common Stock Sale -$136K -591 -0.78% $229.75 75.2K 12 Sep 2025 Direct F1, F5
holding DAVE Class A Common Stock 2.2K 12 Sep 2025 By Family Foundation
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 5, 2025.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $226.35 to $227.34, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $227.36 to $228.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $228.38 to $229.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $229.39 to $230.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.